Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 6/20 | 0.36 |
| ▸ | CNR1 | P21554 | 4/20 | 0.36 |
| ▸ | OXER1 | Q8TDS5 | 4/20 | 0.35 |
| ▸ | PPARG | P37231 | 2/20 | 0.35 |
| ▸ | PPARD | Q03181 | 2/20 | 0.35 |
| ▸ | PPARA | Q07869 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | FAAH | O00519 | 1/20 | 0.32 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11720586 | 0.85 | ALDH1A1 (0.39) | ALDH1A1TSHR | |
| SCHEMBL11720593 | 0.85 | ALDH1A1 (0.39) | ALDH1A1TSHR | |
| SCHEMBL13604722 | 0.80 | CNR2 (0.38) | CNR2CNR1PPARGPPARDPPARA | |
| SCHEMBL4407971 | 0.78 | PPARA (0.46) | CNR2CNR1PPARGPPARDPPARA | |
| SCHEMBL4407967 | 0.78 | PPARA (0.46) | CNR2CNR1PPARGPPARDPPARA | |
| SCHEMBL6866865 | 0.78 | PPARA (0.46) | CNR2CNR1PPARGPPARDPPARA | |
| SCHEMBL5568055 | 0.78 | PPARA (0.46) | CNR2CNR1PPARGPPARDPPARA | |
| SCHEMBL13604759 | 0.78 | CNR2 (0.40) | CNR2CNR1PPARGPPARDPPARA | |
| SCHEMBL13078110 | 0.78 | OXER1 (0.47) | CNR2CNR1OXER1PPARGPPARA | |
| SCHEMBL26497469 | 0.77 | CNR2 (0.36) | CNR2CNR1PPARGPPARDPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090318548-A1 | PARA-QUINOL DERIVATIVES AND METHODS OF STEREO SELECTIVELY SYNTHESIZING AND USING SAME | UNIVERSITY OF NORTHERN BRITISH COLUMBIA (CA) | 2009-12-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090318548-A1 | PARA-QUINOL DERIVATIVES AND METHODS OF STEREO SELECTIVELY SYNTHESIZING AND USING SAME | CBR3, XDH, NQO2 | CNR2 725/4885CNR1 433/4885OXER1 199/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.